Effects of ACE inhibition and AT1 receptor blockade on cardiac ischaemia-reperfusion induced mortality and cardiac markers in rats

Turkish Journal of Medical Sciences

Volumn 35, Issue 6, 2005, Pages 371-377

  Iraz, Mustafa ^a   Şahin, Şemsettin ^b   Ölmez, Ercüment ^a   Acet, Ahmet ^a  

^a INONU UNIVERSITY   (Turkey)

^b GAZIOSMANPASA UNIVERSITY   (Turkey)

Author keywords

Arrhythima; Captopril; Cardiac Marker; Losartan; Myocardial Ischemia Reperfusion; Troponin

Indexed keywords

BIOCHEMISTRY; BIOMARKERS; BLOOD; CARDIOLOGY; ENZYME INHIBITION;

ARRHYTHMIAS; CARDIAC MARKERS; MYOGLOBIN; TROPONIN;

ENZYMES;

ANGIOTENSIN 1 RECEPTOR ANTAGONIST; ASPARTATE AMINOTRANSFERASE; BIOLOGICAL MARKER; CAPTOPRIL; CREATINE KINASE; CREATINE KINASE MB; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; LOSARTAN; MYOGLOBIN; TROPONIN I; TROPONIN T;

ANESTHESIA INDUCTION; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; BLOOD PRESSURE MONITORING; BLOOD SAMPLING; COMPARATIVE STUDY; CONTROLLED STUDY; CREATINE KINASE BLOOD LEVEL; DEATH; DISEASE MARKER; DRUG EFFECT; ELECTROCARDIOGRAM; ENZYME INHIBITION; HEART ARRHYTHMIA; HEART INFARCTION; HEART MUSCLE ISCHEMIA; HEART RATE; HEART VENTRICLE FIBRILLATION; MALE; MORTALITY; NONHUMAN; RAT; REACTION TIME; RECEPTOR BLOCKING; REPERFUSION INJURY; STATISTICAL SIGNIFICANCE; TIME SERIES ANALYSIS;

EID: 32044433495     PISSN: 13000144     EISSN: 13036165     Source Type: Journal    
DOI: None     Document Type: Article

References (34)

1. Braunwald E, Zipes DP, Libby P. Heart Disease: A Textbook of Cardiovascular Medicine, W.B. Saunders Company, Philadelphia pp: 988, 1114-1127, 1131-1134, 2001.
2. Maxwell SR, Lip GY. Reperfusion injury: a review of the pathophysiology, clinical manifestations and therapeutic options. Int J Cardiol. 58: 95-117, 1997.
3. Adams JE 3rd, Abendschein DR, Jaffe AS. Biochemical markers of myocardial injury. Is MB creatine kinase the choice for the 1990s? Circulation. 88: 750-63, 1993.
4. Adams JE 3rd, Bodor GS, Davila-Roman VG et al. Cardiac troponin I. A marker with high specificity for cardiac injury. Circulation. 88: 101-6, 1993.
5. Mair J, Dienstl F, Puschendorf B. Cardiac troponin T in the diagnosis of myocardial injury. Crit Rev Clin Lab Sci. 29: 31-57, 1992.
6. Liu YH, Yang XP, Sharov VG et al. Paracrine systems in the cardioprotective effect of angiotensin-converting enzyme inhibitors on myocardial ischemia/reperfusion injury in rats. Hypertension. 27: 7-13, 1996.
7. Birincioglu M, Aksoy T, Olmez E et al. Protective effect of ACE inhibitors on ischemia-reperfusion-induced arrhythmias in rats: is this effect related to the free radical scavenging action of these drugs? Free Radic Res. 27: 389-96, 1997.
8. Westlin W, Mullane K. Does captopril attenuate reperfusion-induced myocardial dysfunction by scavenging free radicals? Circulation. 77: 130-9, 1988.
9. van Gilst WH, de Graeff PA, Wesseling H et al. Reduction of reperfusion arrhythmias in the ischemic isolated rat heart by angiotensin converting enzyme inhibitors: a comparison of captopril, enalapril, and HOE 498. J Cardiovasc Pharmacol. 8: 722-8, 1986.
10. Di Pasquale P, Paterna S, Cannizzaro S et al. Captopril and glutathione before thrombolysis in acute myocardial infarction: a pilot study. Drugs Exp Clin Res. 18: 401-6, 1992.
11. Özer MK, Sahna E, Birincioglu M et al. Effects of captopril and losartan on myocardial ischemia-reperfusion induced arrhythmias and necrosis in rats. Pharmacol Res. 45: 257-63, 2002.
12. Harada K, Komuro I, Hayashi D et al. Angiotensin II type 1a receptor is involved in the occurrence of reperfusion arrhythmias. Circulation. 97: 315-7, 1998.
13. Katzung BG: Basic & Clinical Pharmacology, the McGraw-Hill companies, Singapore 2004, pp: 178-179.
14. Schwarz ER, Montino H, Fleischhauer J et al. Angiotensin II receptor antagonist EXP 3174 reduces infarct size comparable with enalaprilat and augments preconditioning in the pig heart. Cardiovasc Drugs Ther. 11: 687-95, 1997.
15. Walker MJ, Curtis MJ, Hearse DJ et al. The Lambeth Conventions: guidelines for the study of arrhythmias in ischaemia infarction, and reperfusion. Cardiovasc Res. 22: 447-55, 1988.
16. Linz W, Wiemer G, Gohlke P et al. Contribution of kinins to the cardiovascular actions of angiotensin-converting enzyme inhibitors. Pharmacol Rev. 47: 25-49, 1995.
17. Brunner F, Kukovetz WR. Postischemic antiarrhythmic effects of angiotensin-converting enzyme inhibitors. Role of suppression of endogenous endothelin secretion. Circulation. 94: 1752-61, 1996.
18. Scholkens BA, Linz W, Konig W. Effects of the angiotensin converting enzyme inhibitor, ramipril, in isolated ischaemic rat heart are abolished by a bradykinin antagonist. J Hypertens Suppl. 6: S25-8, 1988.
19. van Wijngaarden J, Tio RA, van Gilst WH et al. Basic pharmacology of ACE-inhibitors with respect to ischaemic heart disease: prostaglandins and bradykinin. Eur Heart J. 11S B: 84-93, 1990.
20. Wiemer G, Scholkens BA, Becker RH et al. Ramiprilat enhances endothelial autacoid formation by inhibiting breakdown of endothelium-derived bradykinin. Hypertension. 18: 558-63, 1991.
21. Akula A, Veeravalli KK, Potharaju S et al. Studies on the signal cascade mechanism mediating the cardioprotective actions of bradykinin. Pharmazie. 57: 332-6, 2002.
22. Kawabata H, Ryomoto T, Ishikawa K. Cardioprotection with angiotensin converting enzyme inhibitor and angiotensin II type 1 receptor antagonist is not abolished by nitric oxide synthase inhibitor in ischemia-reperfused rabbit hearts. Hypertens Res. 24: 403-9, 2001.
23. Divisova J, Vavrinkova H, Tutterova M et al. Effect of ACE inhibitor captopril and L-arginine on the metabolism and on ischemia-reperfusion injury of the isolated rat heart. Physiol Res. 50: 143-52, 2001.
24. Vavrinkova H, Tutterova M, Stopka P et al. The effect of captopril on nitric oxide formation and on generation of radical forms of mitochondrial respiratory chain compounds in ischemic rat heart. Physiol Res. 50: 481-9, 2001.
25. Butz S, Driamov S, Remondino A et al. Losartan but not enalaprilat acutely reduces reperfusion ventricular tachyarrhythmias in hypertrophied rat hearts after low-flow ischaemia. J Pharm Pharmacol. 56: 521-8, 2004.
26. Harada K, Komuro I, Shiojima I et al. Pressure overload induces cardiac hypertrophy in angiotensin II type 1A receptor knockout mice. Circulation. 97: 1952-9, 1998.
27. Thandroyen FT, McCarthy J, Burton KP et al. Ryanodine and caffeine prevent ventricular arrhythmias during acute myocardial ischemia and reperfusion in rat heart. Circ Res. 62: 306-14, 1988.
28. Timmermans PB, Benfield P, Chiu AT et al. Angiotensin II receptors and functional correlates. Am J Hypertens. 5: 221S-235S, 1992.
29. Apple FS. Creatine kinase isoforms and myoglobin: early detection of myocardial infarction and reperfusion. Coron Artery Dis. 10: 75-9, 1999.
30. Bertinchant JP, Larue C, Pernel I et al. Release kinetics of serum cardiac troponin I in ischemic myocardial injury. Clin Biochem. 29: 587-94, 1996.
31. Burlina A, Zaninotto M, Secchiero S et al. Troponin T as a marker of ischemic myocardial injury. Clin Biochem. 27: 113-21, 1994.
32. Katus HA, Remppis A, Neumann FJ et al. Diagnostic efficiency of troponin T measurements in acute myocardial infarction. Circulation. 83: 902-12, 1991.
33. Fredericks S, Merton GK, Lerena MJ et al. Cardiac troponins and creatine kinase content of striated muscle in common laboratory animals. Clin Chim Acta. 304: 65-74, 2001.
34. Vorderwinkler KP, Mair J, Puschendorf B et al. Cardiac troponin I increases in parallel to cardiac troponin T, creatine kinase and lactate dehydrogenase in effluents from isolated perfused rat hearts after hypoxia-reoxygenation-induced myocardial injury. Clinica Chimica Acta 251: 113-7, 1996.